Details for Patent: 8,377,916
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
Which drugs does patent 8,377,916 protect, and when does it expire?
Patent 8,377,916 protects OCALIVA and is included in one NDA.
This patent has seventeen patent family members in thirteen countries.
Summary for Patent: 8,377,916
| Title: | Steroids as agonists for FXR |
| Abstract: | The invention relates to compounds of formula (I): ##STR00001## wherein R is ethyl, propyl or allyl, and pharmaceutically acceptable salts, solvates or amino acid conjugates thereof. The compounds of formula (I) are useful as FXR agonists. |
| Inventor(s): | Pellicciari; Roberto (Perugia, IT) |
| Assignee: | Intercept Pharmaceuticals, Inc. (New York, NY) |
| Application Number: | 13/288,558 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; |
Drugs Protected by US Patent 8,377,916
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-001 | May 27, 2016 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) | ⤷ Sign Up | ||||
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-002 | May 27, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,377,916
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 303399 | ⤷ Sign Up | |||
| Australia | 2002308295 | ⤷ Sign Up | |||
| Belgium | 2017C018 | ⤷ Sign Up | |||
| Canada | 2440680 | ⤷ Sign Up | |||
| Germany | 60205891 | ⤷ Sign Up | |||
| Denmark | 1392714 | ⤷ Sign Up | |||
| European Patent Office | 1392714 | ⤷ Sign Up | 300877 | Netherlands | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
